المؤلفون: Chellapandian H; Lab in Biotechnology and Biosignal Transduction, Department of Orthodontics, Saveetha Dental College and Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai-77, Tamil Nadu, India., Jeyachandran S; Lab in Biotechnology and Biosignal Transduction, Department of Orthodontics, Saveetha Dental College and Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai-77, Tamil Nadu, India. sivakamavalli.sdc@saveetha.com.

المصدر: Neurosurgical review [Neurosurg Rev] 2024 Sep 25; Vol. 47 (1), pp. 681. Date of Electronic Publication: 2024 Sep 25.

نوع المنشور: Journal Article; Letter

بيانات الدورية: Publisher: Springer Berlin Heidelberg Country of Publication: Germany NLM ID: 7908181 Publication Model: Electronic Cited Medium: Internet ISSN: 1437-2320 (Electronic) Linking ISSN: 03445607 NLM ISO Abbreviation: Neurosurg Rev Subsets: MEDLINE

مواضيع طبية MeSH: Decitabine*/pharmacology , Decitabine*/therapeutic use , Meningioma*/genetics , Meningioma*/drug therapy , Meningioma*/pathology , Meningeal Neoplasms*/genetics , Meningeal Neoplasms*/drug therapy , Meningeal Neoplasms*/pathology , Oncogenes*/genetics, Humans ; Antimetabolites, Antineoplastic/therapeutic use ; Gene Expression Regulation, Neoplastic/drug effects

المؤلفون: Peng Z; Nanfang-Chunfu Children's Institute of Hematology & Oncology, TaiXin Hospital, Dongguan, China., Gao J; Department of Pediatrics, Nanfang Hospital, Southern Medical University, Guangzhou, China., Huang L; School of Forensic Medicine, Southern Medical University, Guangzhou, China., He Y; Nanfang-Chunfu Children's Institute of Hematology & Oncology, TaiXin Hospital, Dongguan, China., Tang H; Nanfang-Chunfu Children's Institute of Hematology & Oncology, TaiXin Hospital, Dongguan, China., Zong S; Nanfang-Chunfu Children's Institute of Hematology & Oncology, TaiXin Hospital, Dongguan, China., Pei Y; Nanfang-Chunfu Children's Institute of Hematology & Oncology, TaiXin Hospital, Dongguan, China., Pei F; Department of Pediatrics, Nanfang Hospital, Southern Medical University, Guangzhou, China., Ge J; Department of Pediatrics, Nanfang Hospital, Southern Medical University, Guangzhou, China., Liu X; Department of Pediatrics, Nanfang Hospital, Southern Medical University, Guangzhou, China., Yue L; Nanfang-Chunfu Children's Institute of Hematology & Oncology, TaiXin Hospital, Dongguan, China., Zhou J; Nanfang-Chunfu Children's Institute of Hematology & Oncology, TaiXin Hospital, Dongguan, China., Li X; Nanfang-Chunfu Children's Institute of Hematology & Oncology, TaiXin Hospital, Dongguan, China., Yue D; Nanfang-Chunfu Children's Institute of Hematology & Oncology, TaiXin Hospital, Dongguan, China., Chen Y; Pediatric Hematology Laboratory, Division of Hematology/Oncology, Department of Pediatrics, The Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen, China., Chen C; Department of Biostatistics, Gobroad Research Center, Shanghai, China., Wu X; Department of Pediatrics, Nanfang Hospital, Southern Medical University, Guangzhou, China., Feng X; Department of Pediatrics, Nanfang Hospital, Southern Medical University, Guangzhou, China., Li C; Nanfang-Chunfu Children's Institute of Hematology & Oncology, TaiXin Hospital, Dongguan, China.

المصدر: Frontiers in immunology [Front Immunol] 2024 Aug 26; Vol. 15, pp. 1426640. Date of Electronic Publication: 2024 Aug 26 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Decitabine*/therapeutic use , Decitabine*/administration & dosage , Hematopoietic Stem Cell Transplantation*/adverse effects , Leukemia, Myelomonocytic, Juvenile*/therapy , Leukemia, Myelomonocytic, Juvenile*/mortality, Humans ; Retrospective Studies ; Female ; Male ; Child, Preschool ; Treatment Outcome ; Infant ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Child ; Vidarabine/analogs & derivatives ; Vidarabine/therapeutic use ; Vidarabine/administration & dosage ; Cytarabine/therapeutic use ; Cytarabine/administration & dosage

المؤلفون: Zhang P; Department of Medical Oncology, Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, 310022, China.; Key Laboratory of Tumor Molecular Diagnosis and Individualized Medicine of Zhejiang Province, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, Zhejiang, 310014, China.; Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, 310022, China., Tao C; Department of Radiation Oncology, The Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, Zhejiang, 310022, China.; Key Laboratory of Head and Neck Cancer Translational Research of Zhejiang Province, Zhejiang Cancer Hospital, Hangzhou, Zhejiang, 310022, China., Lu Y; Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, 310022, China., Li P; Department of Radiation Oncology, The Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, Zhejiang, 310022, China.; Key Laboratory of Head and Neck Cancer Translational Research of Zhejiang Province, Zhejiang Cancer Hospital, Hangzhou, Zhejiang, 310022, China., Wang X; Department of Head and Neck Surgery, The Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, Zhejiang, 310022, China., Dai Y; MabPlex International, Yantai, Shandong, 264006, China., Xi Y; Department of Pathology, The Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, Zhejiang, 310022, China., Shimura T; Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Nagoya, 467-8601, Japan., Li X; MabPlex International, Yantai, Shandong, 264006, China., Fang J; School of Materials Science and Engineering, Tianjin University, Tianjin, 300072, China., Yang L; Department of Medical Oncology, Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, 310022, China.; Key Laboratory of Tumor Molecular Diagnosis and Individualized Medicine of Zhejiang Province, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, Zhejiang, 310014, China., He D; Department of Urology, Children's Hospital of Chongqing Medical University, Chongqing, China., Guo P; Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, 310022, China.

المصدر: Advanced science (Weinheim, Baden-Wurttemberg, Germany) [Adv Sci (Weinh)] 2024 Aug; Vol. 11 (30), pp. e2400203. Date of Electronic Publication: 2024 Jun 14.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: WILEY-VCH Country of Publication: Germany NLM ID: 101664569 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2198-3844 (Electronic) Linking ISSN: 21983844 NLM ISO Abbreviation: Adv Sci (Weinh) Subsets: MEDLINE

مواضيع طبية MeSH: Intercellular Adhesion Molecule-1*/genetics , Intercellular Adhesion Molecule-1*/metabolism , Melanoma*/drug therapy , Melanoma*/genetics , Immunoconjugates*/pharmacology , Immunoconjugates*/therapeutic use , Epigenesis, Genetic*/drug effects , Epigenesis, Genetic*/genetics , Decitabine*/pharmacology , Decitabine*/therapeutic use , Disease Models, Animal*, Animals ; Mice ; Tumor Microenvironment/drug effects ; Tumor Microenvironment/immunology ; Cell Line, Tumor ; Humans

المؤلفون: Anabtawi N; Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH, USA., Drabison T; Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH, USA., Jin Y; Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH, USA., Eisenmann ED; Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH, USA., Sparreboom A; Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH, USA., Govindarajan R; Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH, USA., Baker SD; Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH, USA. Electronic address: baker.2480@osu.edu., Ahmed E; Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH, USA.

المصدر: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences [J Chromatogr B Analyt Technol Biomed Life Sci] 2024 Jul 15; Vol. 1242, pp. 124209. Date of Electronic Publication: 2024 Jun 14.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101139554 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-376X (Electronic) Linking ISSN: 15700232 NLM ISO Abbreviation: J Chromatogr B Analyt Technol Biomed Life Sci Subsets: MEDLINE

مواضيع طبية MeSH: Tandem Mass Spectrometry*/methods , Decitabine*/pharmacokinetics , Decitabine*/blood , Decitabine*/administration & dosage, Animals ; Mice ; Chromatography, High Pressure Liquid/methods ; Reproducibility of Results ; Azacitidine/pharmacokinetics ; Azacitidine/blood ; Azacitidine/analogs & derivatives ; Azacitidine/administration & dosage ; Azacitidine/chemistry ; Linear Models ; Uridine/pharmacokinetics ; Uridine/blood ; Uridine/analogs & derivatives ; Sensitivity and Specificity ; Limit of Detection

المؤلفون: Kroonen JS; Department of Cell and Chemical Biology, Leiden University Medical Centre, Leiden, The Netherlands., Wouters AK; Department of Hematology, Leiden University Medical Centre, Leiden, The Netherlands., de Graaf IJ; Department of Cell and Chemical Biology, Leiden University Medical Centre, Leiden, The Netherlands., Remst DFG; Department of Hematology, Leiden University Medical Centre, Leiden, The Netherlands., Kumar S; Department of Cell and Chemical Biology, Leiden University Medical Centre, Leiden, The Netherlands., Wachsmann TLA; Department of Hematology, Leiden University Medical Centre, Leiden, The Netherlands., Teunisse AFAS; Department of Cell and Chemical Biology, Leiden University Medical Centre, Leiden, The Netherlands., Roelands JP; Department of Pathology, Leiden University Medical Centre, Leiden, The Netherlands., de Miranda NFCC; Department of Pathology, Leiden University Medical Centre, Leiden, The Netherlands., Griffioen M; Department of Hematology, Leiden University Medical Centre, Leiden, The Netherlands., Heemskerk MHM; Department of Hematology, Leiden University Medical Centre, Leiden, The Netherlands vertegaal@lumc.nl m.h.m.heemskerk@lumc.nl., Vertegaal ACO; Department of Cell and Chemical Biology, Leiden University Medical Centre, Leiden, The Netherlands vertegaal@lumc.nl m.h.m.heemskerk@lumc.nl.

المصدر: Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Sep 26; Vol. 12 (9). Date of Electronic Publication: 2024 Sep 26.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Decitabine*/pharmacology , Decitabine*/therapeutic use , Epigenesis, Genetic*/drug effects , Receptors, Antigen, T-Cell*/metabolism, Animals ; Mice ; Humans ; Protein Processing, Post-Translational ; Cell Line, Tumor ; Multiple Myeloma/drug therapy ; Multiple Myeloma/immunology ; Multiple Myeloma/metabolism

المؤلفون: Thomas J; Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University Medical Center Freiburg, Hugstetterstr. 55, 79106, Freiburg, Germany., Rehman UU; Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University Medical Center Freiburg, Hugstetterstr. 55, 79106, Freiburg, Germany., Bresser H; Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University Medical Center Freiburg, Hugstetterstr. 55, 79106, Freiburg, Germany., Grishina O; Faculty of Medicine, University Medical Center Freiburg, Clinical Trials Unit, Freiburg, Germany., Pfeifer D; Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University Medical Center Freiburg, Hugstetterstr. 55, 79106, Freiburg, Germany., Sollier E; Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany., Döhner K; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Plass C; Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany., Becker H; Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University Medical Center Freiburg, Hugstetterstr. 55, 79106, Freiburg, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Freiburg, Freiburg, Germany., Schmoor C; Faculty of Medicine, University Medical Center Freiburg, Clinical Trials Unit, Freiburg, Germany., de Wit M; Department of Hematology, Oncology and Palliative Medicine, Vivantes Klinikum Neukoelln, Berlin, Germany., Lübbert M; Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University Medical Center Freiburg, Hugstetterstr. 55, 79106, Freiburg, Germany. Michael.luebbert@uniklinik-freiburg.de.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Freiburg, Freiburg, Germany. Michael.luebbert@uniklinik-freiburg.de.

المصدر: Clinical epigenetics [Clin Epigenetics] 2024 Sep 11; Vol. 16 (1), pp. 126. Date of Electronic Publication: 2024 Sep 11.

نوع المنشور: Journal Article; Case Reports

بيانات الدورية: Publisher: Biomed Central Country of Publication: Germany NLM ID: 101516977 Publication Model: Electronic Cited Medium: Internet ISSN: 1868-7083 (Electronic) Linking ISSN: 18687075 NLM ISO Abbreviation: Clin Epigenetics Subsets: MEDLINE

مواضيع طبية MeSH: Decitabine*/therapeutic use , Decitabine*/administration & dosage , Leukemia, Myeloid, Acute*/drug therapy , Leukemia, Myeloid, Acute*/genetics , Tretinoin*/therapeutic use , Remission Induction*/methods , Tumor Suppressor Protein p53*/genetics, Humans ; Aged, 80 and over ; Mutation ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Male ; Karyotype ; Female

المؤلفون: Cao S; Department of Hematology, The Second Hospital of Anhui Medical University, Hefei, Anhui, P.R. China., Tao Q, Wang J, Zhang Q, Dong Y

المصدر: American journal of therapeutics [Am J Ther] 2024 Sep-Oct 01; Vol. 31 (5), pp. e550-e552. Date of Electronic Publication: 2021 Aug 16.

نوع المنشور: Letter; Case Reports; Journal Article

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9441347 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1536-3686 (Electronic) Linking ISSN: 10752765 NLM ISO Abbreviation: Am J Ther Subsets: MEDLINE

مواضيع طبية MeSH: Decitabine*/therapeutic use , Decitabine*/pharmacology , Receptors, Colony-Stimulating Factor*/genetics , Repressor Proteins*/genetics , Leukemia, Neutrophilic, Chronic*/genetics , Leukemia, Neutrophilic, Chronic*/drug therapy , Mutation*, Humans ; Nuclear Proteins/genetics ; Antimetabolites, Antineoplastic/therapeutic use ; Carrier Proteins/genetics ; Male ; Female ; Middle Aged ; Aged ; Treatment Outcome

المؤلفون: Handa S; Division of Hematology & Oncology, Department of Internal Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY., Sivakumar G; Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH., Srisuwananukorn A; Division of Hematology & Oncology, Department of Internal Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY; Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH., Dueck A; Department of Quantitative Health Sciences, Mayo Clinic, Scottsdale, AZ., Tremblay D; Division of Hematology & Oncology, Department of Internal Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY., Mascarenhas JO; Division of Hematology & Oncology, Department of Internal Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY., Ginzburg Y; Division of Hematology & Oncology, Department of Internal Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY., Kremyanskaya M; Division of Hematology & Oncology, Department of Internal Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY., Hoffman R; Division of Hematology & Oncology, Department of Internal Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY. Electronic address: ronald.hoffman@mssm.edu.

المصدر: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2024 Sep; Vol. 24 (9), pp. e314-e319. Date of Electronic Publication: 2024 May 14.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE

مواضيع طبية MeSH: Primary Myelofibrosis*/drug therapy , Primary Myelofibrosis*/mortality , Decitabine*/therapeutic use , Decitabine*/pharmacology , Decitabine*/administration & dosage , Janus Kinase 2*/antagonists & inhibitors , Janus Kinase 2*/genetics, Humans ; Aged ; Male ; Female ; Aged, 80 and over ; Middle Aged ; Retrospective Studies ; Uridine/analogs & derivatives ; Uridine/therapeutic use ; Uridine/pharmacology ; Uridine/administration & dosage ; Administration, Oral ; Treatment Outcome ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/pharmacology

المؤلفون: Valdez BC; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA., Tsimberidou AM; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA., Yuan B; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA., Baysal MA; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA., Chakraborty A; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA., Andersen CR; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Andersson BS; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.

المصدر: International journal of molecular sciences [Int J Mol Sci] 2024 Aug 26; Vol. 25 (17). Date of Electronic Publication: 2024 Aug 26.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

مواضيع طبية MeSH: Decitabine*/pharmacology , Drug Synergism* , Histone Deacetylase Inhibitors*/pharmacology , Ovarian Neoplasms*/drug therapy , Ovarian Neoplasms*/metabolism , Ovarian Neoplasms*/pathology , Phthalazines*/pharmacology , Poly(ADP-ribose) Polymerase Inhibitors*/pharmacology , Breast Neoplasms*/drug therapy , Breast Neoplasms*/pathology , Breast Neoplasms*/metabolism , Cell Proliferation*/drug effects , Piperazines*/pharmacology, Humans ; Female ; Cell Line, Tumor ; Vorinostat/pharmacology ; Panobinostat/pharmacology ; Apoptosis/drug effects ; Antineoplastic Combined Chemotherapy Protocols/pharmacology ; Hydroxamic Acids/pharmacology ; MCF-7 Cells

المؤلفون: Alfardan AS; Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia., Nadeem A; Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia. Electronic address: anadeem@ksu.edu.sa., Ahmad SF; Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia., Al-Harbi NO; Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia., Alqinyah M; Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia., Attia SM; Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia., El-Sherbeeny AM; Industrial Engineering Department, College of Engineering, King Saud University, Riyadh 11421, Saudi Arabia., Al-Harbi MM; Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia., Al-Shabanah OA; Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia., Ibrahim KE; Department of Zoology, College of Science, King Saud University, Riyadh 11451, Saudi Arabia., Alhazzani K; Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia., Alanazi AZ; Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.

المصدر: International immunopharmacology [Int Immunopharmacol] 2024 Aug 20; Vol. 137, pp. 112503. Date of Electronic Publication: 2024 Jun 20.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 100965259 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-1705 (Electronic) Linking ISSN: 15675769 NLM ISO Abbreviation: Int Immunopharmacol Subsets: MEDLINE

مواضيع طبية MeSH: DNA Methylation*/drug effects , Psoriasis*/chemically induced , Psoriasis*/drug therapy , Psoriasis*/immunology , Psoriasis*/pathology , Decitabine*/pharmacology , Decitabine*/therapeutic use , DNA (Cytosine-5-)-Methyltransferase 1*/antagonists & inhibitors , DNA (Cytosine-5-)-Methyltransferase 1*/metabolism , Skin*/pathology , Skin*/drug effects , Skin*/immunology , Diethylhexyl Phthalate*/toxicity, Animals ; Mice ; Male ; Anti-Inflammatory Agents/therapeutic use ; Anti-Inflammatory Agents/pharmacology ; Cytokines/metabolism ; Disease Models, Animal ; Mice, Inbred BALB C ; Female